Tactac, Guillermo P.
HRN: 26-10-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/14/2025
12/20/2025
IV
2.25g
Q6
CAP-MR
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines